Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Methyl-Life is a specialized nutraceutical company that develops and distributes high-potency L-methylfolate supplements, primarily targeting individuals with MTHFR gene mutations. The company's product line includes various forms of bioactive folate, such as the patented Magnafolate-C, along with synergistic B-vitamins and cofactors. These products are designed to support the methylation cycle, which is critical for neurotransmitter synthesis, detoxification, and cardiovascular health. Methyl-Life serves a global customer base through its e-commerce platform, providing therapeutic-grade options for managing conditions like depression, anxiety, and fatigue related to genetic folate processing issues.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Methyl-Life.